Barbara Gayle Duncan Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Barbara Gayle Duncan.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Barbara Gayle Duncan. Barbara Gayle Duncan is Chief Financial Officer in INTERCEPT PHARMACEUTICALS INC ($ICPT).
Latest Insider Trading Transactions of Barbara Gayle Duncan
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jul 03 2014 | ICPT | INTERCEPT PHARMACE ... | Duncan Barbara Gayle | Chief Financial Off ... | Option Exercise | M | 0.00 | 1,298 | 0 | 7,789 | |
Jul 03 2014 | ICPT | INTERCEPT PHARMACE ... | Duncan Barbara Gayle | Chief Financial Off ... | Buy | M | 0.00 | 1,298 | 0 | 14,808 | 13.5 K to 14.8 K (+9.61 %) |
Jan 17 2014 | ICPT | INTERCEPT PHARMACE ... | Duncan Barbara Gayle | Chief Financial Off ... | Option Exercise | M | 31.90 | 5,625 | 179,438 | 16,875 | |
Jan 17 2014 | ICPT | INTERCEPT PHARMACE ... | Duncan Barbara Gayle | Chief Financial Off ... | Sell | S | 283.90 | 250 | 70,975 | 10,708 | 11 K to 10.7 K (-2.28 %) |
Jan 17 2014 | ICPT | INTERCEPT PHARMACE ... | Duncan Barbara Gayle | Chief Financial Off ... | Sell | S | 280.00 | 125 | 35,000 | 10,958 | 11.1 K to 11 K (-1.13 %) |
Jan 17 2014 | ICPT | INTERCEPT PHARMACE ... | Duncan Barbara Gayle | Chief Financial Off ... | Sell | S | 274.00 | 50 | 13,700 | 11,083 | 11.1 K to 11.1 K (-0.45 %) |
Jan 17 2014 | ICPT | INTERCEPT PHARMACE ... | Duncan Barbara Gayle | Chief Financial Off ... | Sell | S | 265.00 | 250 | 66,250 | 11,133 | 11.4 K to 11.1 K (-2.20 %) |
Jan 17 2014 | ICPT | INTERCEPT PHARMACE ... | Duncan Barbara Gayle | Chief Financial Off ... | Sell | S | 264.00 | 250 | 66,000 | 11,383 | 11.6 K to 11.4 K (-2.15 %) |
Jan 17 2014 | ICPT | INTERCEPT PHARMACE ... | Duncan Barbara Gayle | Chief Financial Off ... | Sell | S | 263.00 | 250 | 65,750 | 11,633 | 11.9 K to 11.6 K (-2.10 %) |
Jan 17 2014 | ICPT | INTERCEPT PHARMACE ... | Duncan Barbara Gayle | Chief Financial Off ... | Sell | S | 262.00 | 250 | 65,500 | 11,883 | 12.1 K to 11.9 K (-2.06 %) |
Jan 17 2014 | ICPT | INTERCEPT PHARMACE ... | Duncan Barbara Gayle | Chief Financial Off ... | Sell | S | 260.00 | 500 | 130,000 | 12,133 | 12.6 K to 12.1 K (-3.96 %) |
Jan 17 2014 | ICPT | INTERCEPT PHARMACE ... | Duncan Barbara Gayle | Chief Financial Off ... | Sell | S | 258.30 | 500 | 129,150 | 12,633 | 13.1 K to 12.6 K (-3.81 %) |
Jan 17 2014 | ICPT | INTERCEPT PHARMACE ... | Duncan Barbara Gayle | Chief Financial Off ... | Sell | S | 257.27 | 750 | 192,950 | 13,133 | 13.9 K to 13.1 K (-5.40 %) |
Jan 17 2014 | ICPT | INTERCEPT PHARMACE ... | Duncan Barbara Gayle | Chief Financial Off ... | Sell | S | 256.00 | 500 | 128,000 | 13,883 | 14.4 K to 13.9 K (-3.48 %) |
Jan 17 2014 | ICPT | INTERCEPT PHARMACE ... | Duncan Barbara Gayle | Chief Financial Off ... | Sell | S | 255.00 | 500 | 127,500 | 14,383 | 14.9 K to 14.4 K (-3.36 %) |
Jan 17 2014 | ICPT | INTERCEPT PHARMACE ... | Duncan Barbara Gayle | Chief Financial Off ... | Sell | S | 253.63 | 1,150 | 291,675 | 14,883 | 16 K to 14.9 K (-7.17 %) |
Jan 17 2014 | ICPT | INTERCEPT PHARMACE ... | Duncan Barbara Gayle | Chief Financial Off ... | Sell | S | 251.55 | 300 | 75,465 | 16,033 | 16.3 K to 16 K (-1.84 %) |
Jan 17 2014 | ICPT | INTERCEPT PHARMACE ... | Duncan Barbara Gayle | Chief Financial Off ... | Buy | M | 31.90 | 5,625 | 179,438 | 16,333 | 10.7 K to 16.3 K (+52.53 %) |
Page: 1